Spark2Flame, Inc. (S2F) is a preclinical-stage biopharmaceutical company developing novel therapeutics for the treatment of neuropsychiatric disorders. Our team is deeply committed to improving the lives of patients suffering from neurological and psychiatric diseases, and operate in a dynamic, results-oriented environment.